Sales rise 18.08% to Rs 6037.90 crore
Net profit of Zydus Lifesciences rose 38.13% to Rs 1258.60 crore in the quarter ended September 2025 as against Rs 911.20 crore during the previous quarter ended September 2024. Sales rose 18.08% to Rs 6037.90 crore in the quarter ended September 2025 as against Rs 5113.60 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended |
| Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 6037.90 | 5113.60 | 18 |
| OPM % | 33.39 | 28.58 | - |
| PBDT | 2023.50 | 1504.50 | 34 |
| PBT | 1721.60 | 1270.90 | 35 |
| NP | 1258.60 | 911.20 | 38 |
Powered by Capital Market - Live News